Contribution of the complement Membrane Attack Complex to the bactericidal activity of human serum

Molecular Immunology

Volumn 65, Issue 2, 2015, Pages 328-335

  Berends, Evelien T M ^a   Mohan, Sarbani ^a   Miellet, Willem R ^a   Ruyken, Maartje ^a   Rooijakkers, Suzan H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bactericidal assay; Complement; Gram negative bacteria; Membrane Attack Complex; Serum

Indexed keywords

COMPLEMENT COMPONENT C5 INHIBITOR; COMPLEMENT COMPONENT C5 INHIBITOR OMCI; COMPLEMENT COMPONENT C5A; COMPLEMENT MEMBRANE ATTACK COMPLEX; UNCLASSIFIED DRUG; ARTHROPOD PROTEIN; CARRIER PROTEIN; COMPLEMENT COMPONENT C5; OMCI PROTEIN, TICK;

ARTICLE; BACTERIAL VIABILITY; BLOOD LEVEL; BURKHOLDERIA CEPACIA; COMPLEMENT BLOOD LEVEL; COMPLEMENT SYSTEM; CONTROLLED STUDY; DRUG POTENCY; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; HEAT TREATMENT; HUMAN; HUMORAL IMMUNITY; KLEBSIELLA PNEUMONIAE; LYSIS; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERUM BACTERICIDAL ACTIVITY; SERUM FACTOR; ANTAGONISTS AND INHIBITORS; GRAM NEGATIVE BACTERIUM; IMMUNOLOGY; SPECIES DIFFERENCE;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

ARTHROPOD PROTEINS; BLOOD BACTERICIDAL ACTIVITY; CARRIER PROTEINS; COMPLEMENT C5; COMPLEMENT MEMBRANE ATTACK COMPLEX; GRAM-NEGATIVE BACTERIA; HUMANS; SPECIES SPECIFICITY;

EID: 84925640200     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2015.01.020     Document Type: Article

References (38)

1. Barratt-Due A., Thorgersen E.B., Lindstad J.K., Pharo A., Lissina O., Lambris J.D., Nunn M.A., Mollnes T.E. Ornithodoros moubata complement inhibitor is an equally effective C5 inhibitor in pigs and humans. J. Immunol. 2011, 187:4913-4919.
2. Bayer M.E. Areas of adhesion between wall and membrane of Escherichia coli. J. Gen. Microbiol. 1968, 53:395-404.
3. Berends E.T.M., Dekkers J.F., Nijland R., Kuipers A., Soppe J.A., van Strijp J.A.G., Rooijakkers S.H.M. Distinct localization of the complement C5b-9 complex on Gram-positive bacteria. Cell. Microbiol. 2013, 15:1955-1968.
4. Berends E.T.M., Kuipers A., Ravesloot M.M., Urbanus R.T., Rooijakkers S.H.M. Bacteria under stress by complement and coagulation. FEMS Microbiol. Rev. 2014, 38:1146-1171.
5. Bestebroer J., Aerts P.C., Rooijakkers S.H.M., Pandey M.K., Köhl J., van Strijp J.A.G., de Haas C.J.C. Functional basis for complement evasion by staphylococcal superantigen-like 7. Cell. Microbiol. 2010, 12:1506-1516.
6. Callewaert L., Michiels C.W. Lysozymes in the animal kingdom. J. Biosci. 2010, 35:127-160.
7. Dankert J.R., Esser A.F. Complement-mediated killing of Escherichia coli: dissipation of membrane potential by a C9-derived peptide. Biochemistry 1986, 25:1094-1100.
8. Davis S.D., Wedgwood R.J. Kinetics of the bactericidal action of normal serum on Gram-negative bacteria. J. Immonol. 1965, 95:75-79.
9. Dobrina A., Pausa M., Fischetti F., Bulla R., Vecile E., Ferrero E., Mantovani A., Tedesco F. Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo. Blood 2002, 99:185-192.
10. Frank M.M., Joiner K., Hammer C. The function of antibody and complement in the lysis of bacteria. Rev. Infect. Dis. 1987, 9:S537-S545.
11. Gerard C., Gerard N.P. C5A anaphylatoxin and its seven transmembrane-segment receptor. Annu. Rev. Immunol. 1994, 12:775-808.
12. Granoff D.M. Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease. Vaccine 2009, 27(Suppl. 2):B117-B125.
13. Hepburn N.J., Williams A.S., Nunn M.A., Chamberlain-Banoub J.C., Hamer J., Morgan B.P., Harris C.L. In vivo characterization and therapeutic efficacy of a C5-specific inhibitor from the soft tick Ornithodoros moubata. J. Biol. Chem. 2007, 282:8292-8299.
14. Joiner K.A., Brown E.J., Frank M.M. Complement and bacteria: chemistry and biology in host defense. Annu. Rev. Immunol. 1984, 2:461-491.
15. Joisel F., Leroux-Nicollet I., Lebreton J.P., Fontaine M. A hemolytic assay for clinical investigation of human C2. J. Immunol. Methods 1983, 59:229-235.
16. Kashyap D.R., Wang M., Liu L.-H., Boons G.-J., Gupta D., Dziarski R. Peptidoglycan recognition proteins kill bacteria by activating protein-sensing two-component systems. Nat. Med. 2011, 17:676-683.
17. Kew R.R., Peng T., DiMartino S.J., Madhaven D., Weinman S.J., Cheng D., Prossnitz E.R. Undifferentiated U937 cells transfected with chemoattractant receptors: a model system to investigate chemotactic mechanisms and receptor structure/function relationships. J. Leukoc. Biol. 1997, 61:329-337.
18. Langley R., Wines B., Willoughby N., Proft T., Fraser J.D., Basu I. The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-FcaRI binding and serum killing of bacteria. J. Immunol. 2005, 174:2926-2933.
19. Mckeage K. Eculizumab A review of its use in paroxysmal nocturnal haemoglobinuria. Drugs 2011, 71:2327-2345.
20. Mee-Jung H., Lee S.Y., Hong S.H. Comparative analysis of envelope proteomes in Escherichia coli B and K-12 strains. J. Microbiol. Biotechnol. 2012, 22:470-478.
21. Müller-Eberhard H.J. The membrane attack complex of complement. Annu. Rev. Immunol. 1986, 4:503-528.
22. Nordahl E.A., Rydengård V., Nyberg P., Nitsche D.P., Mörgelin M., Malmsten M., Björck L., Schmidtchen A. Activation of the complement system generates antibacterial peptides. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:16879-16884.
23. Nunn M.A., Sharma A., Paesen G.C., Adamson S., Lissina O., Willis A.C., Nuttall P.A. Complement inhibitor of C5 activation from the soft tick Ornithodoros moubata. J. Immunol. 2005, 174:2084-2091.
24. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
25. Rooijakkers S.H.M., Rasmussen S.L., McGillivray S.M., Bartnikas T.B., Mason A.B., Friedlander A.M., Nizet V. Human transferrin confers serum resistance against Bacillus anthracis. J. Biol. Chem. 2010, 285:27609-27613.
26. Root R.K., Ellman L., Frank M.M. Bactericidal and opsonic properties of C4-deficient guinea pig serum. J. Immunol. 1972, 109:477-486.
27. Rowley D., Wardlaw A.C. Lysis of gram-negative bacteria by serum. J. Gen. Microbiol. 1958, 18:529-533.
28. Silhavy T.J., Kahne D., Walker S. The bacterial cell envelope. Cold Spring Harbor Perspectives in Biology 2010, 2.
29. Skarnes R.C. Humoral bactericidal systems: nonspecific and specific mechanisms. Infect. Immun. 1978, 19:515-522.
30. Skattum L., van Deuren M., van der Poll T., Truedsson L. Complement deficiency states and associated infections. Mol. Immunol. 2011, 48:1643-1655.
31. Studier F.W., Daegelen P., Lenski R.E., Maslov S., Kim J.F. Understanding the differences between genome sequences of Escherichia coli B strains REL606 and BL21(DE3) and comparison of the E. coli B and K-12 genomes. J. Mol. Biol. 2009, 394:653-680.
32. Taylor P.W. Sensitivity of some smooth strains of Escherichia coli to the bactericidal action of normal human serum. J. Clin. Pathol. 1974, 27:626-629.
33. Taylor P.W. Bactericidal and bacteriolytic activity of serum against Gram-negative bacteria. Microbiol. Rev. 1983, 47:46-83.
34. Tedesco B.F., Pausa M., Nardon E., Introna M., Mantovani A., Dobrina A. The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity. J. Exp. Med. 1997, 185:1619-1627.
35. Vermeer A.W.P., Norde W. The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein. Biophys. J. 2000, 78:394-404.
36. Walport M.J. Complement first of two parts. N. Engl. J. Med. 2001, 344:1058-1066.
37. Wretlind B., Becker K., Haas D. IncP-1 Rplasmids decrease the serum resistance and the virulence of Pseudomonas aeruginosa. J. Gen. Microbiol. 1985, 131:2701-2704.
38. Xie X., McLean M.D., Hall J.C. Antibody-dependent cell-mediated cytotoxicity- and complement-dependent cytotoxicity-independent bactericidal activity of an IgG against Pseudomonas aeruginosa O6ad. J. Immunol. 2010, 184:3725-3733.